Claret Medical
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $1.3m | Early VC | |
N/A | $164k | Debt | |
N/A | $250k | Debt | |
N/A | $3.4m | Series A | |
N/A | $3.6m | Debt | |
$18.0m | Series B | ||
N/A | Series C | ||
$14.5m | Series C | ||
$270m Valuation: $270m | Acquisition | ||
Total Funding | CAD50.7m |
Related Content
Recent News about Claret Medical
EditClaret Medical specializes in developing advanced cerebral protection systems designed to safeguard patients during cardiovascular procedures. Operating in the medical device industry, Claret Medical serves healthcare professionals and institutions focused on interventional cardiology. The company's core product, the Sentinel Cerebral Protection System, is engineered to capture and remove debris dislodged during heart valve procedures, thereby reducing the risk of stroke. Claret Medical generates revenue through the sale of its proprietary medical devices and ongoing support services. The company targets hospitals, clinics, and specialized cardiovascular centers, aiming to improve patient outcomes and procedural safety.
Keywords: cerebral protection, cardiovascular procedures, medical devices, interventional cardiology, stroke prevention, healthcare professionals, Sentinel system, debris capture, patient safety, procedural innovation.